For a hedged play on Baxter International (BAX) MarketIntelligenceCenter.com’s patented trade-picking algorithms selected a May 18, 2018 $67.50 covered call for a net debit in the $65 area. That is also the break-even stock price for …
Leerink Partners analyst Michael Schmidt reiterated an Outperform rating and $27 price target on uniQure BV (NASDAQ: QURE), saying the discontinuation of Shire's (NASDAQ: SHPG) BAX 335 program ... a major overhang on the stock. …
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BAX at https://www.zacks.com/ap/BAX
LivingSocial is engaged in serious talks to sell its Korean deals business Ticket Monster ... In a carefully worded statement, LivingSocial CFO John Bax said this week that a deal had not been reached, but little else. Bax said that …
BAX). Halozyme has royalty terms in place with companies interested in using ENHANZE, making the technology a major revenue driver going forward. Halozyme's stock lost half its value when the FDA voiced concerns about the safety of the …
Marissa Mayer's stock surged 4.51% on a day sisters showed Mister Market ... aerospace outfit is initiated with a Buy at Drexel Hamilton. Baxter International Inc. (BAX): Credit Suisse covers the medical device maker at Outperform. …
CHICAGO, Oct 18 (Reuters) - Baxter International Inc (BAX.N) on Thursday posted better-than-expected ... put investor concerns to rest and reaffirm our bullish view on the stock,” Morgan Stanley analyst Glenn Reicin wrote in a research note.
Baxter issued a conservative long-term outlook last week, saying its focus on treatments for unmet medical needs would help insulate it from macroeconomic pressures. Shares of the company closed at $61.92 on Wednesday on the New …